During the past decade, AKDHC Medical Research Services, LLC conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 9 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AKDHC Medical Research Services, LLC" #1 sponsor was "Gilead Sciences" with 2 trials, followed by "Humacyte, Inc." with 2 trials sponsored, "Proteon Therapeutics" with 2 trials sponsored, "Trevi Therapeutics" with 2 trials sponsored and "Abbott" with 2 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AKDHC Medical Research Services, LLC" #1 collaborator was "CTI Clinical Trial and Consulting Services" with 2 trials as a collaborator, "California Institute for Regenerative Medicine (CIRM)" with 2 trials as a collaborator, "Harvard University" with 1 trials as a collaborator, "Massachusetts General Hospital" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "AKDHC Medical Research Services, LLC" are "Diabetic Kidney Disease" (3 trials), "Renal Failure" (3 trials), "Uremic Pruritus" (3 trials), "Chronic Kidney Disease" (2 trials) and "End Stage Renal Disease" (2 trials). Many other conditions were trialed in "AKDHC Medical Research Services, LLC" in a lesser frequency.

Most popular intervention types in "AKDHC Medical Research Services, LLC" are "Drug" (18 trials), "Device" (3 trials), "Biological" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Human Acellular Vessel (HAV)" (2 trials), "Acetaminophen" (1 trials), "Acthar Gel" (1 trials) and "Arteriovenous fistula (AVF)" (1 trials). Other intervention names were less common.

The vast majority of trials in "AKDHC Medical Research Services, LLC" are 22 trials for "All" genders.

Currently, there are NaN active trials in "AKDHC Medical Research Services, LLC". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in AKDHC Medical Research Services, LLC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in AKDHC Medical Research Services, LLC, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".